-
Africa: WHO Launches Council to Develop TB Vaccines
UN News, 17 January 2023
The head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, has unveiled plans to speed up the licensing and use of effective novel vaccines against tuberculosis… Read more »
-
Africa: WHO Announces Plans to Establish a TB Vaccine Accelerator Council
WHO, 18 January 2023
The adverse impact of the COVID-19 pandemic on tuberculosis (TB) services has brought the urgency of vaccine development efforts into sharp focus. Speaking earlier today at a… Read more »
-
South Africa: South African Researchers Break New Ground in TB Vaccine Research - South African News Briefs - January 12, 2023
allAfrica, 12 January 2023
South African Researchers Bring Hope for Developing New TB Vaccines Read more »
-
Africa: Groundbreaking MSF Trial Finds Better Treatment for People With Drug-Resistant Tuberculosis
MSF, 21 December 2022
A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options for people with… Read more »
WHO's TB Vaccine Accelerator Council Could Save Millions of Lives
The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus has announced a plan to create a new Tuberculosis Vaccine Accelerator Council.
Speaking at the World Economic Forum Davos, Ghebreyesus said the mechanism should accelerate coordination among funders, global agencies, governments and end users to identify and remove barriers to TB vaccine development. In this way, the Tuberculosis Vaccine Accelerator Council will facilitate the licensing and use of new effective TB vaccines.
The Director-General made the announcement considering the urgency of stepping up vaccine development efforts against the disease as the epidemic shows no signs of slowing down. Currently, the Bacillus Calmette-Guérin (BCG) vaccine, developed in 1921, is the only licensed TB vaccine, according to the WHO. While BCG provides moderate efficacy in preventing severe forms of TB in infants and young children, it does not adequately protect adolescents and adults, who account for nearly 90% of TB transmissions globally.
InFocus
-
The results of a clinical trial, published in the New England Journal of Medicine, has shown that a new six-month regimen for drug-resistant tuberculosis (DR-TB) is safer, more ... Read more »
-
According to early findings from the landmark TRUNCATE TB trial presented at the Union World Conference on Lung Health, some cases of tuberculosis (TB) can be successfully treated ... Read more »
-
According to Spotlight, evidence is mounting that, as with Covid-19, people can have active TB disease and be infectious without having any symptoms. The use of digi Read more »
-
The 7th South African TB Conference is under way in Durban, where the health care community is looking at the progress and challenges facing a country that has some of the highest ... Read more »
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization.
